Preclinical Testing Shows Breezy aHP Activity Against Candida auris
Candida auris (C. auris) is an emerging multidrug-resistant fungus that is a growing concern for...
Stay up-to-date on Breezy Med and infection prevention automation with our press releases, blog articles, and case studies.
Candida auris (C. auris) is an emerging multidrug-resistant fungus that is a growing concern for...
Breezy Med is pleased to share the publication of a new peer-reviewed article in the Journal of...
Coming in the second week of February, we’re releasing a major software update for Breezy Blue that...
We’re excited to announce the release of Breezy Cloud v1.13, now live across customer accounts and...
As Breezy Med has expanded the Breezy platform, our customers’ needs have become more diverse. Some...
Breezy Med is entering an exciting new chapter. Our automated aerosolized hydrogen peroxide (aHP)...
On December 8, 2025, Breezy Med is launching new Breezy Cloud™ tiers designed to give hospitals...
Breezy BioCare™ RTU (BioCare) has served our customers well for years, but we’re excited to...
This year’s flu season is proving to be one of the most challenging in over a decade. Hospitals...
A recent Becker’s Hospital Review report revealed that measles cases are climbing across the United...
We are excited to announce the release of Breezy Cloud™ v1.11.0, which introduces new functionality...
Infection prevention is one of the greatest challenges in long-term acute care hospitals. With...